top of page
OIP (Oncology Impact Partners) invests in, and strategically supports, private oncology companies developing innovative approaches to cancer treatment and diagnosis.
OIP is a venture capital fund investing solely in innovative oncology technologies focused on delivering improved patient outcomes
OIP's VISION IS EVERY CANCER PATIENT DESERVES A CURE.
OIP’s mission is to invest in and support the most innovative private companies developing cancer therapeutic and diagnostic technologies.
OIP’s partners and advisers provide active, on-going business development, finance, regulatory, scientific, and strategic support to maximize each company's probability of success and patient impact.
OIP's general partner contributes 5% of the carried interest it receives to the National Foundation for Cancer Research (NFCR) to support non-profit academic research as well as an additional 5% to other cancer-related charities.
bottom of page